Filing Details
- Accession Number:
- 0001209191-21-067888
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-03 17:09:16
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-12-03 17:09:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-01 | 15 | $2.67 | 5,769,789 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-02 | 15 | $2.63 | 5,769,804 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-03 | 15 | $2.71 | 5,769,819 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-04 | 15 | $2.73 | 5,769,834 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-05 | 15 | $2.71 | 5,769,849 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-08 | 15 | $2.95 | 5,769,864 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-09 | 15 | $3.21 | 5,769,879 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-10 | 15 | $2.94 | 5,769,894 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-11 | 15 | $2.83 | 5,769,909 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-12 | 15 | $2.67 | 5,769,924 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-15 | 15 | $2.71 | 5,769,939 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-16 | 15 | $2.66 | 5,769,954 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-17 | 15 | $2.58 | 5,769,969 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-18 | 15 | $2.58 | 5,769,984 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-19 | 15 | $2.55 | 5,769,999 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-22 | 15 | $2.35 | 5,770,014 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-23 | 15 | $2.29 | 5,770,029 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-24 | 35 | $2.31 | 5,770,064 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-26 | 35 | $2.26 | 5,770,099 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-29 | 35 | $2.23 | 5,770,134 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-11-30 | 35 | $4.61 | 5,770,169 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
